Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren’s Syndrome

키워드

참고문헌 (36)

1. Thomas E, "Sjogren’s syndrome : a community-based study of prevalence and impact", Br J Rheumatol, 37, pp.1069~1076 (1998)
2. Jacobsson LT, "Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjogren’s syndrome", J Autoimmun, 2, pp.521~527 (1989)
3. Bjerrum KB, "Keratoconjunctivitis sicca and primary Sjogren’s syndrome in a Danish population aged 30-60years", Acta Ophthalmol Scand, 75, pp.281~286 (1997)
4. Jonsson R, "Current concepts on diagnosis, autoantibodies and therapy in Sjogren’s syndrome", Scand J Rheumatol, 29, pp.341~348 (2000)
5. Mavragani CP, "Sjogren’s syndrome", Annu Rev Pathol, 9, pp.273~285 (2014)
6. El Annan J, "Characterization of effector T cells in dry eye disease", Invest Ophthalmol Vis Sci, 50, pp.3802~3807 (2009)
7. De Paiva CS, "IL-17disrupts corneal barrier following desiccating stress", Mucosal Immunol, 2, pp.243~253 (2009)
8. Zoukhri D, "Effect of inflammation on lacrimal gland function", Exp Eye Res, 82, pp.885~898 (2006)
9. Luo L, "Experimental dry eye stimulates production of inflammatory cytokines and MMP-9and activates MAPK signaling pathways on the ocular surface", Invest Ophthalmol Vis Sci, 45, pp.4293~4301 (2004)
10. Siemasko KF, "In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation", Invest Ophthalmol Vis Sci, 49, pp.5434~5440 (2008)
11. Chauhan SK, "Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression", J Immunol, 182, pp.1247~1252 (2009)
12. Li DQ, "Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells", Invest Ophthalmol Vis Sci, 45, pp.4302~4311 (2004)
13. Li DQ, "Hyperosmolarity stimulates production of MMP-9, IL-1ß and TNF-by human corneal epithelial cells via a c-Jun NH2-terminal kinase pathway", Invest Ophthalmol Vis Sci, 43, pp.1981~ (2002)
14. Goto E, "Tear evaporation rates in Sjogren syndrome and non-Sjogren dry eye patients", Am J Ophthalmol, 144, pp.81~85 (2007)
15. Long Q, "Comparison of corneal biomechanics in Sjogren’s syndrome and non-Sjogren’s syndrome dry eyes by Scheimpflug based device", Int J Ophthalmol, 10, pp.711~716 (2017)
16. Bron AJ, "Diagnosis of dry eye", Surv Ophthalmol, 45, pp.S221~S226 (2001)
17. Martinez-Carrasco R, "Assessment of dry eye in a GVHD murine model : approximation through tear osmolarity measurement", Exp Eye Res, 154, pp.64~69 (2017)
18. Berchicci L, "Tear osmolarity in ocular graft-versus-host disease", Cornea, 33, pp.1252~1256 (2014)
19. Stevenson W, "Dry eye disease : an immune-mediated ocular surface disorder", Arch Ophthalmol, 130, pp.90~100 (2012)
20. Pflugfelder SC, "Altered cytokine balance in the tear f luid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca", Curr Eye Res, 19, pp.201~211 (1999)
21. Messmer EM, "Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay", Ophthalmology, 123, pp.2300~2308 (2016)
22. Chotikavanich S, "Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome", Invest Ophthalmol Vis Sci, 50, pp.3203~3209 (2009)
23. Shiboski CH, "2016 American College of Rheumatology", European League Against Rheumatism classification criteria for primary Sjogren’s syndrome : a consensus and data-driven methodology involving three international patient cohorts, 2017, pp.76, 9~16
24. Schiffman RM, "Reliability and validity of the ocular surface disease index", Arch Ophthalmol, 118, pp.615~621 (2000)
25. Whitcher JP, "A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry", Am J Ophthalmol, 149, pp.405~415 (2010)
26. Lemp MA, "Tear osmolarity in the diagnosis and management of dry eye disease", Am J Ophthalmol, 151, pp.792~798 (2011)
27. Jacobi C, "Tear film osmolarity measurements in dry eye disease using electrical impedance technology", Cornea, 30, pp.1289~1292 (2011)
28. Sullivan B, "Challenges in using signs and symptoms to evaluate new biomarkers of dry eye disease", Ocul Surf, 12, pp.2~9 (2014)
29. Kaufman HE, "The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications", Cornea, 32, pp.211~216 (2013)
30. Mishima S, "The tear flow dynamics in normal and in keratoconjunctivitis sicca cases", Ophthalmology: proceedings of the XXI International Congress, pp.1801~1805 (1971), Excerpta Medica
31. Suzuki M, "Tear osmolarity as a biomarker for dry eye disease severity", Invest Ophthalmol Vis Sci, 51, pp.4557~4561 (2010)
32. 김미리내, "Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren’s Syndrome", Korean Journal of Ophthalmology, 31(1), pp.25~31 (2017), 대한안과학회
33. Tomlinson A, "Tear film osmolarity : determination of a referent for dry eye diagnosis", Invest Ophthalmol Vis Sci, 47, pp.4309~4315 (2006)
34. Lanza NL, "Dry eye profiles in patients with a positive elevated surface matrix metalloproteinase 9 point-of-care test versus negative patients", Ocul Surf, 14, pp.216~223 (2016)
35. Sambursky R, "Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye", JAMA Ophthalmol, 131, pp.24~28 (2013)
36. Schargus M, "Correlation of tear film osmolarity and 2 different MMP-9 tests with common dry eye tests in a cohort of non-dry eye patients", Cornea, 34, pp.739~744 (2015)

관련 논문AI추천